Do not take Wegovy pills if you: Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Are pregnant, planning to become pregnant, or breastfeeding all GLP-1 medication should be stopped at least 2 months before attempting to conceive Are allergic to semaglutide, SNAC coating, or any other ingredient in the tablet Have severe gastroparesis or significant gastrointestinal disease Have a history of vision problems related to your diabetes Have pancreatitis Tell your prescriber about any medication you are taking including vitamins , supplements and over the counter medications, particularly if you take any of the following: Levothyroxine : thyroid hormone levels should be monitored Warfarin or other anticoagulants : oral Wegovy may affect INR through dietary changes and changes in gastric motility Anti-epilepsy medicines: some epilepsy medicines such as phenytoin require careful monitoring as they have a narrow dosing range Ciclosporin : narrow therapeutic index

Withdrawal symptoms can include Increased appetite Decreased satiety Elevated blood sugar levels Weight gain Elevated blood pressure and other cardiovascular changes A study from a 2022 clinical trial that tested semaglutide treatment for weight loss found that participants had regained about two-thirds of their initial weight loss on average, and many patients also experienced raised blood pressure levels
Sitagliptin was obtained from Stratech Scientific (Ely, UK)
Unveils Apaly RxDynamic Rx Routing to Lowest Net-Cost GLP-1 Fulfillment for Self-Funded Employers and Commercial Health Plans
All Desma Pharm peptides are manufactured in Italy
While semaglutide helps reduce calorie intake and promote weight loss, exercise helps your body lose fat instead of muscle, maintain strength, and improve long-term metabolic health